BIO
Price
$251.56
Change
+$0.91 (+0.36%)
Updated
Jul 3 closing price
Capitalization
9.79B
19 days until earnings call
BRKR
Price
$42.45
Change
-$0.01 (-0.02%)
Updated
Jul 3 closing price
Capitalization
12.93B
25 days until earnings call
Interact to see
Advertisement

BIO vs BRKR

Header iconBIO vs BRKR Comparison
Open Charts BIO vs BRKRBanner chart's image
Bio-Rad Laboratories
Price$251.56
Change+$0.91 (+0.36%)
Volume$109.09K
Capitalization9.79B
Bruker
Price$42.45
Change-$0.01 (-0.02%)
Volume$1.21M
Capitalization12.93B
BIO vs BRKR Comparison Chart in %
Loading...
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIO vs. BRKR commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a Buy and BRKR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (BIO: $251.56 vs. BRKR: $42.45)
Brand notoriety: BIO and BRKR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BIO: 29% vs. BRKR: 51%
Market capitalization -- BIO: $9.79B vs. BRKR: $12.93B
BIO [@Medical Specialties] is valued at $9.79B. BRKR’s [@Medical Specialties] market capitalization is $12.93B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIO’s FA Score shows that 0 FA rating(s) are green whileBRKR’s FA Score has 1 green FA rating(s).

  • BIO’s FA Score: 0 green, 5 red.
  • BRKR’s FA Score: 1 green, 4 red.
According to our system of comparison, BRKR is a better buy in the long-term than BIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIO’s TA Score shows that 6 TA indicator(s) are bullish while BRKR’s TA Score has 6 bullish TA indicator(s).

  • BIO’s TA Score: 6 bullish, 2 bearish.
  • BRKR’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, BIO is a better buy in the short-term than BRKR.

Price Growth

BIO (@Medical Specialties) experienced а +3.32% price change this week, while BRKR (@Medical Specialties) price change was +0.64% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.95%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was -0.02%.

Reported Earning Dates

BIO is expected to report earnings on Jul 24, 2025.

BRKR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+1.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRKR($12.9B) has a higher market cap than BIO($9.79B). BRKR has higher P/E ratio than BIO: BRKR (32.04) vs BIO (3.64). BIO YTD gains are higher at: -23.424 vs. BRKR (-27.411). BRKR has higher annual earnings (EBITDA): 676M vs. BIO (-654.76M). BIO has more cash in the bank: 1.61B vs. BRKR (488M). BRKR (1.38B) and BIO (1.41B) have identical debt. BRKR has higher revenues than BIO: BRKR (2.96B) vs BIO (2.67B).
BIOBRKRBIO / BRKR
Capitalization9.79B12.9B76%
EBITDA-654.76M676M-97%
Gain YTD-23.424-27.41185%
P/E Ratio3.6432.0411%
Revenue2.67B2.96B90%
Total Cash1.61B488M329%
Total Debt1.41B1.38B102%
FUNDAMENTALS RATINGS
BIO vs BRKR: Fundamental Ratings
BIO
BRKR
OUTLOOK RATING
1..100
3931
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9583
PRICE GROWTH RATING
1..100
5457
P/E GROWTH RATING
1..100
853
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BRKR's Valuation (71) in the Medical Specialties industry is in the same range as BIO (80). This means that BRKR’s stock grew similarly to BIO’s over the last 12 months.

BRKR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as BIO (100). This means that BRKR’s stock grew similarly to BIO’s over the last 12 months.

BRKR's SMR Rating (83) in the Medical Specialties industry is in the same range as BIO (95). This means that BRKR’s stock grew similarly to BIO’s over the last 12 months.

BIO's Price Growth Rating (54) in the Medical Specialties industry is in the same range as BRKR (57). This means that BIO’s stock grew similarly to BRKR’s over the last 12 months.

BRKR's P/E Growth Rating (3) in the Medical Specialties industry is significantly better than the same rating for BIO (85). This means that BRKR’s stock grew significantly faster than BIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOBRKR
RSI
ODDS (%)
Bearish Trend 3 days ago
58%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 3 days ago
70%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
71%
MACD
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 6 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 4 days ago
70%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
67%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
66%
Aroon
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DCOR68.050.49
+0.73%
Dimensional US Core Equity 1 ETF
LEMB40.570.05
+0.12%
iShares JP Morgan EM Local Ccy Bd ETF
BAMD31.60-0.01
-0.02%
Brookstone Dividend Stock ETF
IVRA16.44-0.02
-0.09%
Invesco Real Assets ESG ETF
CPLB21.12-0.07
-0.31%
NYLI MacKay Core Plus Bond ETF

BIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIO has been closely correlated with A. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIO
1D Price
Change %
BIO100%
+0.36%
A - BIO
71%
Closely correlated
+0.60%
TMO - BIO
71%
Closely correlated
+1.86%
DHR - BIO
69%
Closely correlated
+0.35%
MTD - BIO
67%
Closely correlated
+0.28%
BRKR - BIO
65%
Loosely correlated
-0.02%
More

BRKR and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRKR has been closely correlated with A. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if BRKR jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRKR
1D Price
Change %
BRKR100%
-0.02%
A - BRKR
78%
Closely correlated
+0.60%
MTD - BRKR
75%
Closely correlated
+0.28%
RVTY - BRKR
75%
Closely correlated
+0.41%
TMO - BRKR
70%
Closely correlated
+1.86%
WAT - BRKR
68%
Closely correlated
-0.48%
More